Harrison.ai has petitioned the FDA to exempt some radiology AI devices from premarket review, prompting mixed feedback from industry stakeholders.
Key Details
- 1Harrison.ai seeks FDA exemption for certain computer-aided detection (CAD) AI devices from premarket review.
- 2The company argues current US regulatory pathways are too burdensome for rapidly evolving AI.
- 3Stakeholder comments included feedback from RSNA, ACR, and Patient Alliance for Safe Imaging.
- 4ACR emphasized the need to prioritize patient safety and warned against unintended safety risks.
- 5Harrison.ai has 8 FDA clearances covering 12 indications and its products serve over 1,000 facilities in 40 countries.
- 6Consulting firm Rubrum Advising submitted the petition in October 2023.
Why It Matters
If granted, this exemption could significantly alter the regulatory landscape for radiology AI software, balancing innovation access against patient safety concerns. The decision will set a precedent for future AI device oversight in imaging.
Source
Radiology Business
Related News
•Radiology Business
Epsilon Health Launches With $28M to Build 'AI-Native' Imaging Practice
Epsilon Health has exited stealth mode, raising nearly $28M to launch an 'AI-native' radiology imaging group aimed at addressing the U.S. radiologist shortage.
•Radiology Business
Harrison.ai Restructures and Launches U.S. AI-Enabled Teleradiology Venture
Harrison.ai lays off staff amid major restructuring and launches Frontier Radiology, an AI-powered U.S. teleradiology business.
•Radiology Business
Elucid Secures $55M Series D to Expand AI Cardiovascular Imaging
Elucid raises $55M Series D to advance its AI software for cardiovascular CT analysis.